AustralieFrV1, PubMed, Corpus, bibRecord, 000893

New discoveries in the pathogenesis and classification of vitiligo.

Identifieur interne : 000893 ( PubMed/Corpus ); précédent : 000892; suivant : 000894

New discoveries in the pathogenesis and classification of vitiligo.

Auteurs : Michelle Rodrigues ; Khaled Ezzedine ; Iltefat Hamzavi ; Amit G. Pandya ; John E. Harris

Source :

Journal of the American Academy of Dermatology [ 1097-6787 ] ; 2017.

RBID : pubmed:28619550

English descriptors

KwdEn :
- Humans, Vitiligo (classification), Vitiligo (diagnosis), Vitiligo (etiology).
MESH :
- classification : Vitiligo.
- diagnosis : Vitiligo.
- etiology : Vitiligo.
- Humans.

Abstract

Vitiligo is a common autoimmune disease that progressively destroys melanocytes in the skin, resulting in the appearance of patchy depigmentation. This disfiguring condition frequently affects the face and other visible areas of the body, which can be psychologically devastating. The onset of vitiligo often occurs in younger individuals and progresses for life, resulting in a heavy burden of disease and decreased quality of life. Presentation patterns of vitiligo vary, and recognition of these patterns provides both diagnostic and prognostic clues. Recent insights into disease pathogenesis offer a better understanding of the natural history of the disease, its associations, and potential for future treatments. The first article in this continuing medical education series outlines typical and atypical presentations of vitiligo, how they reflect disease activity, prognosis, and response to treatment. Finally, we discuss disease associations, risk factors, and our current understanding of disease pathogenesis.

DOI: 10.1016/j.jaad.2016.10.048
PubMed: 28619550

Links to Exploration step

pubmed:28619550

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">New discoveries in the pathogenesis and classification of vitiligo.</title>
<author><name sortKey="Rodrigues, Michelle" sort="Rodrigues, Michelle" uniqKey="Rodrigues M" first="Michelle" last="Rodrigues">Michelle Rodrigues</name>
<affiliation><nlm:affiliation>Department of Dermatology, St. Vincent's Hospital, The Skin and Cancer Foundation Inc, Victoria, Australia; The Royal Children's Hospital, Victoria, Australia. Electronic address: dr.rodrigues@gmail.com.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Ezzedine, Khaled" sort="Ezzedine, Khaled" uniqKey="Ezzedine K" first="Khaled" last="Ezzedine">Khaled Ezzedine</name>
<affiliation><nlm:affiliation>Department of Dermatology, Henri Mondor Hospital, Creteil, France; EpiDermE, Universite Paris-Est, Creteil, France.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Hamzavi, Iltefat" sort="Hamzavi, Iltefat" uniqKey="Hamzavi I" first="Iltefat" last="Hamzavi">Iltefat Hamzavi</name>
<affiliation><nlm:affiliation>Department of Dermatology, Henry Ford Hospital, Detroit, Michigan.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Pandya, Amit G" sort="Pandya, Amit G" uniqKey="Pandya A" first="Amit G" last="Pandya">Amit G. Pandya</name>
<affiliation><nlm:affiliation>Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Harris, John E" sort="Harris, John E" uniqKey="Harris J" first="John E" last="Harris">John E. Harris</name>
<affiliation><nlm:affiliation>Department of Dermatology, University of Massachusetts Medical School, Worcester, Massachusetts.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2017">2017</date>
<idno type="RBID">pubmed:28619550</idno>
<idno type="pmid">28619550</idno>
<idno type="doi">10.1016/j.jaad.2016.10.048</idno>
<idno type="wicri:Area/PubMed/Corpus">000893</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000893</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">New discoveries in the pathogenesis and classification of vitiligo.</title>
<author><name sortKey="Rodrigues, Michelle" sort="Rodrigues, Michelle" uniqKey="Rodrigues M" first="Michelle" last="Rodrigues">Michelle Rodrigues</name>
<affiliation><nlm:affiliation>Department of Dermatology, St. Vincent's Hospital, The Skin and Cancer Foundation Inc, Victoria, Australia; The Royal Children's Hospital, Victoria, Australia. Electronic address: dr.rodrigues@gmail.com.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Ezzedine, Khaled" sort="Ezzedine, Khaled" uniqKey="Ezzedine K" first="Khaled" last="Ezzedine">Khaled Ezzedine</name>
<affiliation><nlm:affiliation>Department of Dermatology, Henri Mondor Hospital, Creteil, France; EpiDermE, Universite Paris-Est, Creteil, France.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Hamzavi, Iltefat" sort="Hamzavi, Iltefat" uniqKey="Hamzavi I" first="Iltefat" last="Hamzavi">Iltefat Hamzavi</name>
<affiliation><nlm:affiliation>Department of Dermatology, Henry Ford Hospital, Detroit, Michigan.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Pandya, Amit G" sort="Pandya, Amit G" uniqKey="Pandya A" first="Amit G" last="Pandya">Amit G. Pandya</name>
<affiliation><nlm:affiliation>Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Harris, John E" sort="Harris, John E" uniqKey="Harris J" first="John E" last="Harris">John E. Harris</name>
<affiliation><nlm:affiliation>Department of Dermatology, University of Massachusetts Medical School, Worcester, Massachusetts.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">Journal of the American Academy of Dermatology</title>
<idno type="eISSN">1097-6787</idno>
<imprint><date when="2017" type="published">2017</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Humans</term>
<term>Vitiligo (classification)</term>
<term>Vitiligo (diagnosis)</term>
<term>Vitiligo (etiology)</term>
</keywords>
<keywords scheme="MESH" qualifier="classification" xml:lang="en"><term>Vitiligo</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Vitiligo</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Vitiligo</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Humans</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Vitiligo is a common autoimmune disease that progressively destroys melanocytes in the skin, resulting in the appearance of patchy depigmentation. This disfiguring condition frequently affects the face and other visible areas of the body, which can be psychologically devastating. The onset of vitiligo often occurs in younger individuals and progresses for life, resulting in a heavy burden of disease and decreased quality of life. Presentation patterns of vitiligo vary, and recognition of these patterns provides both diagnostic and prognostic clues. Recent insights into disease pathogenesis offer a better understanding of the natural history of the disease, its associations, and potential for future treatments. The first article in this continuing medical education series outlines typical and atypical presentations of vitiligo, how they reflect disease activity, prognosis, and response to treatment. Finally, we discuss disease associations, risk factors, and our current understanding of disease pathogenesis.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28619550</PMID>
<DateCreated><Year>2017</Year>
<Month>06</Month>
<Day>16</Day>
</DateCreated>
<DateCompleted><Year>2017</Year>
<Month>07</Month>
<Day>21</Day>
</DateCompleted>
<DateRevised><Year>2017</Year>
<Month>07</Month>
<Day>21</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1097-6787</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>77</Volume>
<Issue>1</Issue>
<PubDate><Year>2017</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>Journal of the American Academy of Dermatology</Title>
<ISOAbbreviation>J. Am. Acad. Dermatol.</ISOAbbreviation>
</Journal>
<ArticleTitle>New discoveries in the pathogenesis and classification of vitiligo.</ArticleTitle>
<Pagination><MedlinePgn>1-13</MedlinePgn>
</Pagination>
<ELocationID EIdType="pii" ValidYN="Y">S0190-9622(16)31115-X</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jaad.2016.10.048</ELocationID>
<Abstract><AbstractText>Vitiligo is a common autoimmune disease that progressively destroys melanocytes in the skin, resulting in the appearance of patchy depigmentation. This disfiguring condition frequently affects the face and other visible areas of the body, which can be psychologically devastating. The onset of vitiligo often occurs in younger individuals and progresses for life, resulting in a heavy burden of disease and decreased quality of life. Presentation patterns of vitiligo vary, and recognition of these patterns provides both diagnostic and prognostic clues. Recent insights into disease pathogenesis offer a better understanding of the natural history of the disease, its associations, and potential for future treatments. The first article in this continuing medical education series outlines typical and atypical presentations of vitiligo, how they reflect disease activity, prognosis, and response to treatment. Finally, we discuss disease associations, risk factors, and our current understanding of disease pathogenesis.</AbstractText>
<CopyrightInformation>Copyright © 2016 American Academy of Dermatology, Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rodrigues</LastName>
<ForeName>Michelle</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Department of Dermatology, St. Vincent's Hospital, The Skin and Cancer Foundation Inc, Victoria, Australia; The Royal Children's Hospital, Victoria, Australia. Electronic address: dr.rodrigues@gmail.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Ezzedine</LastName>
<ForeName>Khaled</ForeName>
<Initials>K</Initials>
<AffiliationInfo><Affiliation>Department of Dermatology, Henri Mondor Hospital, Creteil, France; EpiDermE, Universite Paris-Est, Creteil, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Hamzavi</LastName>
<ForeName>Iltefat</ForeName>
<Initials>I</Initials>
<AffiliationInfo><Affiliation>Department of Dermatology, Henry Ford Hospital, Detroit, Michigan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Pandya</LastName>
<ForeName>Amit G</ForeName>
<Initials>AG</Initials>
<AffiliationInfo><Affiliation>Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Harris</LastName>
<ForeName>John E</ForeName>
<Initials>JE</Initials>
<AffiliationInfo><Affiliation>Department of Dermatology, University of Massachusetts Medical School, Worcester, Massachusetts.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><CollectiveName>Vitiligo Working Group</CollectiveName>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>J Am Acad Dermatol</MedlineTA>
<NlmUniqueID>7907132</NlmUniqueID>
<ISSNLinking>0190-9622</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014820" MajorTopicYN="N">Vitiligo</DescriptorName>
<QualifierName UI="Q000145" MajorTopicYN="Y">classification</QualifierName>
<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">chemical leukoderma</Keyword>
<Keyword MajorTopicYN="N">confetti depigmentation</Keyword>
<Keyword MajorTopicYN="N">halo nevi</Keyword>
<Keyword MajorTopicYN="N">leukoderma</Keyword>
<Keyword MajorTopicYN="N">segmental vitiligo</Keyword>
<Keyword MajorTopicYN="N">vitiligo</Keyword>
<Keyword MajorTopicYN="N">vitiligo pathogenesis</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year>
<Month>07</Month>
<Day>15</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2016</Year>
<Month>10</Month>
<Day>23</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2016</Year>
<Month>10</Month>
<Day>30</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2017</Year>
<Month>6</Month>
<Day>17</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2017</Year>
<Month>6</Month>
<Day>18</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2017</Year>
<Month>7</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">28619550</ArticleId>
<ArticleId IdType="pii">S0190-9622(16)31115-X</ArticleId>
<ArticleId IdType="doi">10.1016/j.jaad.2016.10.048</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000893 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000893 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:28619550
   |texte=   New discoveries in the pathogenesis and classification of vitiligo.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i   -Sk "pubmed:28619550" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a AustralieFrV1

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024

	Serveur d'exploration sur les relations entre la France et l'Australie
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur les relations entre la France et l'Australie

New discoveries in the pathogenesis and classification of vitiligo.

New discoveries in the pathogenesis and classification of vitiligo.

Source :

English descriptors

Abstract

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki